Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW433908 Expanded Access Program in HIV-Infected Patients
2004-000336-81Phase 3Terminated
- Sponsor
- GSK
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fosamprenavir in human immunodeficiency virus infection (HIV), sponsored by GSK. Started Mar 2007; status: terminated.
02
Drugs
fosamprenavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-000336-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000336-81.